Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q4

Duzce Medical Journal

TurkeyMedicine (miscellaneous) (Q4)ISSN-matched source record
Q4Ranking
—Impact Factor (year unverified)
9H-index (SCImago 2025)
0.179SJR (2025)
2010-2025Coverage

About Duzce Medical Journal

Duzce Medical Journal — Journal Profile

Duzce Medical Journal (short title Duzce Med J; Turkish title Düzce Tıp Fakültesi Dergisi, the journal of the Düzce University Faculty of Medicine) is a peer-reviewed, open-access general medical journal published in Türkiye by the Duzce University Faculty of Medicine through the national DergiPark platform. Its electronic ISSN is 1307-671X — the single ISSN recorded for the title on its DergiPark journal pages and in its directory listings. It appears three times a year, in April, August and December, publishes in English, reviews under double-blind arrangements, and charges authors nothing at any stage: no submission, processing or publication fee under any name. Its pages carry original research, reviews, case reports and editorial material across the basic and clinical medical sciences, and its recent issues mix Turkish clinical research with contributions from further afield, including Central Asia. This profile records its identity and history, scope, editorial practice, verified metrics, indexing, licensing and submission route.

History and identity

The journal is the house journal of a young medical school. Düzce University, in the province of Düzce in Türkiye's western Black Sea region, built its Faculty of Medicine into a full teaching and hospital institution in the 2000s, and its journal grew with it as the faculty's channel for clinical and experimental work. The coverage recorded for the title in Scopus-based listings runs from 2010 onward, and the journal has settled into the rhythm it still keeps: three issues a year, in April, August and December, published on DergiPark, the journal platform operated for Turkish academic publishing by TÜBİTAK ULAKBİM. The bilingual identity is deliberate and should be understood by anyone citing it: the same journal answers to Duzce Medical Journal in English and to Düzce Tıp Fakültesi Dergisi in Turkish, and databases differ in which name they file it under — OpenAlex, for example, carries the source under its Turkish title. Citations, catalogue records and literature searches that use only one of the two names will miss material filed under the other; the ISSN, 1307-671X, is the reliable thread between them.

Two identity cautions follow. First, Duzce Medical Journal is not the only medical journal Düzce University publishes: the university's Faculty of Medicine also stands behind the Konuralp Medical Journal (ISSN 1309-3878), a general medicine and primary care title run from its Department of Family Medicine, with its own DergiPark home and its own rhythm of March, June and October issues. The two titles are siblings, not duplicates, and nothing in this profile's record belongs to Konuralp. Second, the Journals World template that this profile replaces stored the publisher as a bare numeric code; the publisher of record is Duzce University — the Faculty of Medicine — as the journal's DergiPark pages and its Directory of Open Access Journals record both state, and that correction is noted in the sources file for this profile. The journal's abbreviation for citation purposes is Duzce Med. J.

Scope and subjects

The journal's own aim-and-scope statement is broad by design: clinical and experimental studies in all fields of medicine are evaluated for publication, in the form of original research, invited reviews, case reports, and editorial comment and discussion, across both the basic and the clinical sciences. Manuscripts must be unpublished and not under consideration elsewhere, and the publication language is English. A general-scope faculty journal lives or dies by whether its contents actually reflect that breadth, and the journal's latest issue at the time of writing (August 2026) does: histopathology and molecular signalling in fructose-induced lung injury; a randomised controlled trial of kinesio taping for pain and comfort after caesarean section; intensive care management and early outcomes after pancreaticoduodenectomy; an animal study of the myometrium in polycystic ovary syndrome; clinical frailty and readmission after planned intensive care admission; a comparison of two-rod and three-rod instrumentation in corrective spine fusion; bone health in children with cerebral palsy; mid- and long-term outcomes of ankle arthrodesis procedures; a candidate drug inducing ferroptosis-associated death in glioblastoma cells; adiposity indices and gallstone disease; sedation regimens for advanced endoscopy; hepatitis B vaccination coverage in people living with HIV; reference values for chemical elements in the hair of children and adolescents in western Kazakhstan; and case reports ranging from localised amyloidosis of the nasopharynx to a mandibular ameloblastoma in an adolescent.

That spread — surgery, anaesthesia, obstetrics, orthopaedics, oncology, infectious disease, paediatrics, intensive care and laboratory medicine in a single issue — is the scope in action. OpenAlex's topic grouping for the source (which files recent content under headings such as COVID-19 clinical research, reproductive health, long-term effects of COVID-19, inflammatory biomarkers and sperm and testicular function) reflects the pandemic-era weight of its back catalogue. For authors, the practical reading is this: the journal is a genuine general medical outlet, suitable for a solid single-centre clinical study, a well-documented case report or an experimental study that a hyper-specialist title might judge too general, and its readership is the broad community of clinicians and medical researchers who use DergiPark and the indexing services listed below. Highly specialised work aimed at a subspecialty audience will usually find a better-fitting home elsewhere; work whose value is its clinical generality is exactly what this journal exists to carry.

Publisher, editors and editorial practice

The publisher is Duzce University, and the journal is published by its Faculty of Medicine, as the DergiPark journal masthead states (e-ISSN 1307-671X; publisher Duzce University; publication model: periodical, April–August–December). Editorial work is organised through DergiPark, which provides the submission system, the journal's boards pages, its statistics and its policy pages in one place: the journal maintains dedicated DergiPark pages for its aim and scope, price policy, journal boards, author guidelines, ethical principles and publication policy, review process, open access policy, licence policy, copyright statement and archive policy — a fuller public policy suite than many larger journals offer. Peer review is described by the journal as independent, unbiased and double-blinded: authors and reviewers do not learn each other's identities, and the editorial assessment proceeds on the manuscript alone. This profile does not name individual editors, because the board membership shown on the journal's boards pages changes over time and the names verified for earlier profiles of Turkish faculty journals have repeatedly gone stale; authors who need the current board should read it on the DergiPark boards page at the time they submit, where the journal itself keeps it.

Two editorial commitments deserve emphasis because they shape the author experience. The first is cost: the journal's price policy page states that no fee is charged to the author or the institution under any name, and its aim-and-scope page repeats that no submission, processing or publication charges are required — the journal is free to publish in, in the strict sense, funded as a university faculty publication rather than by its authors. The second is openness with a protective licence: the journal is open access, and its content is licensed under a Creative Commons Attribution–NonCommercial–NoDerivatives 4.0 International licence (CC BY-NC-ND), as stated on its DergiPark pages and confirmed by its DOAJ record — readers may share the work with attribution for non-commercial purposes, but may not distribute modified versions. Authors used to the more permissive CC BY terms of many open-access journals should note the NoDerivatives element before submitting, since it governs how their published article may be reused and translated.

Metrics and standing

The journal's metrics are modest and are reported here exactly as their sources give them. SCImago, working from Scopus data, places Duzce Medical Journal in Medicine (miscellaneous) at Q4, with an SJR of 0.179 and an h-index of 9 in its current ranking table, 66 documents published in 2025 and a two-year citations-per-document figure of 0.59 — the profile of an active, mid-sized national journal with a growing document flow. The h-index of 9 matches the figure in the directory template this profile replaces, which verification therefore confirms. In the Journal Citation Reports listing for Turkish ESCI journals, the journal appears in Medicine, General and Internal with a Journal Impact Factor of 0.3 and quartile Q4 (2024 figures, declared June 2025); its presence in the Emerging Sources Citation Index is also shown on its DergiPark masthead. Authors should present the impact factor as an ESCI figure from that JCR listing, sourced and dated, rather than as a bare number.

OpenAlex tells a consistent but differently-bounded story. Resolved through its ISSN endpoint (source S2739443996, filed under the Turkish title Düzce Tıp Fakültesi Dergisi) at the time of checking, it records 515 works and 862 citations, an h-index of 12 and an i10-index of 17, marks the source as open access and as present in DOAJ, and shows recent annual volumes in the mid-sixties of works — matching the document counts in the SCImago table. Its coverage of the source begins in 2018, later than the Scopus coverage recorded from 2010, which is why its totals are lower-bound figures for the journal's whole life. The differences among these numbers — h-index 9 in Scopus-based counting, 12 in OpenAlex — are database effects, not contradictions, and this profile keeps each figure attached to its source so that readers comparing the journal with neighbouring titles compare like with like.

Indexing and access

The journal's DergiPark masthead displays its indexing as: Emerging Sources Citation Index (ESCI), DOAJ, TR Dizin and Scopus. Each element can be independently grounded. Scopus coverage is evidenced by the journal's SCImago record. The DOAJ record was verified directly through the DOAJ search API for ISSN 1307-671X, which returns the journal under its Turkish title with Duzce University as publisher, no article processing charges, and the CC BY-NC-ND licence. TR Dizin is the Turkish national index maintained by TÜBİTAK ULAKBİM, the same body that runs DergiPark, and is the listing of most weight inside the Turkish academic promotion system. Access itself is immediate and free: every article is readable and downloadable from the journal's DergiPark pages, current issue and archive alike, under the CC BY-NC-ND terms described above. For a clinician or researcher, the practical position is simple — if a Duzce Medical Journal article exists, it can be read in full, without a subscription, from the journal's own platform.

How to submit

Submission runs through the journal's DergiPark page (dergipark.org.tr/en/pub/dtfd), using the platform's manuscript submission system; the journal is shown there as open for submissions. Authors should prepare the manuscript in English, in one of the categories the journal evaluates — original research, invited review, case report, or editorial comment and discussion — covering clinical or experimental work in the basic or clinical sciences, and should work from the journal's own author guidelines page on DergiPark for format, structure, ethics declarations and file requirements before uploading, since those guidelines are the operative document and are updated by the journal in place. The manuscript must be unpublished and not under review anywhere else, a condition the journal states explicitly. Review is double-blind, so the submitted files should be prepared with reviewer anonymity in mind. There is no fee at submission, during processing or on publication. With three issues a year (April, August, December), accepted work waits for the next issue slot in the cycle; authors working to a fixed deadline — a promotion file, a thesis defence, a grant report — should count backwards from those three annual dates when judging whether the journal's timetable fits their need.

Inside the journal: reading its role in Turkish medical publishing

To understand what a journal like this is for, it helps to place it in the system that sustains it. Türkiye maintains one of the world's densest ecosystems of university medical journals, most of them published by medical faculties on the shared DergiPark platform and competing for the same national pool of clinical research. In that system, the listings that matter most for an author's career are TR Dizin, the national index, and the Web of Science indexes — ESCI first, with the Journal Impact Factor that ESCI titles now receive — because Turkish academic promotion and appointment criteria award points by index tier. Duzce Medical Journal holds both a TR Dizin presence and ESCI status with a JCR impact factor, which puts it in the working tier of that system: a journal whose papers count, in the formal sense, for the clinicians who publish them, without the extreme competition of the country's handful of large, internationally oriented medical titles. Its three-issue rhythm and general scope make it a realistic destination for the case series, single-centre outcome studies, residency-derived research and case reports that form the bulk of a teaching hospital's scholarly output — work that needs a legitimate, indexed, peer-reviewed home and an audience of practising clinicians rather than a subspecialty elite.

The case-report stream deserves a specific note, because it is larger here than in many general journals and it is doing real work. The current issue's reports — a primary localised amyloidosis of the nasopharynx, a biphenotypic lung carcinoma co-expressing markers that usually exclude each other, a fatal coronary event after contraceptive overdose, an ameloblastoma in an adolescent — are the classic teaching cases of hospital medicine: rare presentations, diagnostic traps and management lessons, written up by the teams that met them. For the junior doctors who author many of them, a case report in an indexed journal is often a first publication and a training exercise in clinical writing; for readers, the reports are the part of the journal most likely to be consulted at the moment a similar patient appears. A general faculty journal that keeps a serious case-report section, reviewed to the same double-blind standard as its research articles, is performing a service to clinical practice that citation metrics do not capture — one more reason this profile reports its modest metrics plainly and without apology, as the record of a working hospital journal rather than a failed bid for prestige.

Related journals

Within Türkiye's crowded field of university medical journals, the closest comparisons are the other faculty titles on DergiPark with general-medicine scope — journals such as the Journal of Experimental and Clinical Medicine, the Eurasian Journal of Medicine, Northern Clinics of Istanbul and the Turkish Journal of Medical Sciences at the larger end of the scale — together with Düzce University's own sibling title, the Konuralp Medical Journal (ISSN 1309-3878), which concentrates on general medicine and primary care from the same faculty's Department of Family Medicine. Duzce Medical Journal's distinguishing marks within that company are its three-issue English-language rhythm, its complete absence of author charges, and a contents mix that gives experimental and basic-science work room alongside clinical studies and case reports. For a Turkish medical researcher, the choice among these titles usually turns on indexing requirements for promotion, the fit of the manuscript's specialty, and which journal's recent issues the intended readers actually follow.

Frequently asked questions

What is the ISSN of Duzce Medical Journal?

Its electronic ISSN is 1307-671X. The journal is an online title on the DergiPark platform, and that single e-ISSN — shared by its English title, Duzce Medical Journal, and its Turkish title, Düzce Tıp Fakültesi Dergisi — is the identifier to use in citations and searches.

Who publishes Duzce Medical Journal?

Duzce University, through its Faculty of Medicine, in Düzce, Türkiye. It is published on the DergiPark platform operated by TÜBİTAK ULAKBİM.

How often does it appear and in what language?

Three times a year, in April, August and December. The publication language is English.

Is the journal peer-reviewed and open access?

Yes on both counts. Review is independent and double-blind, and all content is free to read on DergiPark under a Creative Commons Attribution–NonCommercial–NoDerivatives 4.0 licence.

Does the journal charge authors?

No. Its price policy states that no fee is charged to the author or institution under any name, and its aim-and-scope page confirms that no submission, processing or publication charges are required.

Where is it indexed and what are its metrics?

Its masthead lists ESCI, DOAJ, TR Dizin and Scopus. SCImago reports SJR 0.179, Q4 in Medicine (miscellaneous) and an h-index of 9; the JCR listing for Turkish ESCI journals gives a Journal Impact Factor of 0.3 (2024); OpenAlex reports 515 works, 862 citations and an h-index of 12 at the time of checking.

How do I submit a manuscript?

Through the journal's page on DergiPark, following its author guidelines: an unpublished English manuscript in one of its article categories, prepared for double-blind review, with no fee payable at any stage.

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-07-20. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY-NC-ND
Peer-review processDouble anonymous peer review
APCNo APC reported in the DOAJ snapshot
Waiver policy reportedNo
Other fees reportedNo
Author retains unrestricted copyrightNo
Reported submission-to-publication time20 weeks on average; not a guarantee
Openly licensed content since2015 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)1307-671X
ISSN-L1307-671X
Source typeJournal
Publisher / hosting organisationDüzce University Medical School
Publisher country codeTR
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex515
Citations recorded in OpenAlex862
OpenAlex H-index12
Years represented in OpenAlex2018–2025 (not the founding or closing dates)

Topics in published research

COVID-19 Clinical Research Studies; Reproductive Biology and Fertility; Ovarian function and disorders; Inflammatory Biomarkers in Disease Prognosis; Long-Term Effects of COVID-19; Sperm and Testicular Function.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit